Contemporary Diagnosis and Management of Rheumatic Heart Disease: Implications for Closing the Gap: A Scientific Statement From the American Heart Association.
Kumar RK, Antunes MJ, Beaton A, Mirabel M, Nkomo VT, Okello E, Regmi PR, Reményi B, Sliwa-Hähnle K, Zühlke LJ, Sable C; American Heart Association Council on Lifelong Congenital Heart Disease and Heart Health in the Young; Council on Cardiovascular and Stroke Nursing; and Council on Clinical Cardiology.
Circulation. 2020 Nov 17;142(20):e337-e357. doi: 10.1161/CIR.0000000000000921. Epub 2020 Oct 19.
PMID:33073615
Pregnancy outcomes in relation to disease activity and anti-rheumatic treatment strategies in women with rheumatoid arthritis: a matched cohort study from Sweden and Denmark.
Rheumatology (Oxford). 2022 Aug 30;61(9):3711-3722. doi: 10.1093/rheumatology/keab894.
PMID:34864891
Single-cell resolution of longitudinal blood transcriptome profiles in rheumatoid arthritis, systemic lupus erythematosus and healthy control pregnancies.
Preterm birth in women with psoriatic arthritis: what are the risks and risk factors? A collaborative cohort study from Sweden, Denmark and Norway.
Secher AEP, Granath F, Remaeus K, Glintborg B, Rom AL, Michelsen B, Hetland ML, Hellgren K.
RMD Open. 2025 Oct 5;11(4):e005614. doi: 10.1136/rmdopen-2025-005614.
PMID:41052892
Development and validation of a EULAR disease activity score in antiphospholipid syndrome.
Tektonidou MG, Cervera R, Tincani A, Pons-Estel GJ, Sciascia S, Alijotas-Reig J, Avcin T, Bertolaccini ML, Jasinski T, Marchiori F, Mekinian A, Meroni PL, Pengo V, Radin M, Rahman A, Ruiz-Irastorza G, Schreiber K, Stoilova S, van den Hoogen L, van Vollenhoven R, Wahl D, Stamm T, Landewé RBM, Ward MM; EULAR APS Disease Activity Score Collaborators.
Ann Rheum Dis. 2026 Mar;85(3):399-411. doi: 10.1016/j.ard.2025.10.006. Epub 2025 Nov 19.
PMID:41274853
Multinational evidence-based recommendations for the use of methotrexate in rheumatic disorders with a focus on rheumatoid arthritis: integrating systematic literature research and expert opinion of a broad international panel of rheumatologists in the 3E Initiative.
Visser K, Katchamart W, Loza E, Martinez-Lopez JA, Salliot C, Trudeau J, Bombardier C, Carmona L, van der Heijde D, Bijlsma JW, Boumpas DT, Canhao H, Edwards CJ, Hamuryudan V, Kvien TK, Leeb BF, Martín-Mola EM, Mielants H, Müller-Ladner U, Murphy G, Østergaard M, Pereira IA, Ramos-Remus C, Valentini G, Zochling J, Dougados M.
Ann Rheum Dis. 2009 Jul;68(7):1086-93. doi: 10.1136/ard.2008.094474. Epub 2008 Nov 25.
PMID:19033291
Early-life exposure to tobacco, inflammation, and risk of rheumatic diseases: a prospective cohort study.
Dou X, He M, Wang Y, Huang Y, Zhang Z, Lin H, Yang Y.
J Public Health (Oxf). 2025 Dec 1;47(4):710-720. doi: 10.1093/pubmed/fdaf077.
PMID:40611489
Managing pregnancy in inflammatory rheumatological diseases.
Jain V, Gordon C.
Arthritis Res Ther. 2011 Feb 25;13(1):206. doi: 10.1186/ar3227.